The Hematology Research Training Program at the University of Washington is designed to provide intensive post-doctoral research training in investigative hematology. The program emphasizes cell and molecular biology, with particular strengths in: stem cells and hematopoiesis, cell and gene therapy, platelets and hemostasis, vascular biology, hematologic malignancies, cancer biology, and hematopoietic cell transplantation. Program faculty includes established investigators with strong independent research programs from both basic science and clinical departments at the University of Washington, Fred Hutchinson Cancer Research Center, and nearby affiliated institutions. The goal of the Training Program is to develop the research, presentation, and fund-raising skills that trainees will need to establish independent research careers, and to train future leaders in the field of research hematology. Trainees have MD, MD/PhD or PhD degrees. Many have completed clinical training in hematology, but others are basic researchers wishing to work in the field. Trainees are chosen through an application process and interactions with program faculty. They obtain laboratory experience by working with a mentor, and are assisted in laboratory techniques, publishing papers, presentation skills, and acquiring independent grant support. Trainees typically receive 2 years of funding from the Program, but often continue their training longer under separate funding mechanisms. Training progress is monitored by the faculty mentor, a separate faculty advisor, the Program Directors, and the Division of Hematology faculty through regular research presentations and meetings with each trainee. The main strengths of the Program include: diverse research opportunities, a qualified senior faculty, and a long track record, spanning over four decades of graduates obtaining junior faculty positions and becoming independent and distinguished investigators.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Institutional National Research Service Award (T32)
Project #
5T32HL007093-39
Application #
8470677
Study Section
Special Emphasis Panel (ZHL1-CSR-J (O2))
Program Officer
Chang, Henry
Project Start
1975-07-01
Project End
2015-06-30
Budget Start
2013-07-01
Budget End
2014-06-30
Support Year
39
Fiscal Year
2013
Total Cost
$518,253
Indirect Cost
$38,389
Name
University of Washington
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Gupta, Vikas; Malone, Adriana K; Hari, Parameswaran N et al. (2014) Reduced-intensity hematopoietic cell transplantation for patients with primary myelofibrosis: a cohort analysis from the center for international blood and marrow transplant research. Biol Blood Marrow Transplant 20:89-97
Klippel, Z K; Chou, J; Towlerton, A M et al. (2014) Immune escape from NY-ESO-1-specific T-cell therapy via loss of heterozygosity in the MHC. Gene Ther 21:337-42
Shadman, Mazyar; Estey, Elihu H (2013) Prophylactic use of granulocyte colony-stimulating factor after consolidation therapy with high-dose cytarabine for acute myeloid leukemia. Expert Rev Hematol 6:131-3
Mawad, Raya; Gooley, Ted A; Sandhu, Vicky et al. (2013) Frequency of allogeneic hematopoietic cell transplantation among patients with high- or intermediate-risk acute myeloid leukemia in first complete remission. J Clin Oncol 31:3883-8
Gerds, Aaron T; Gooley, Ted A; Wilson, Wendy A et al. (2013) Components of the revised International Prognostic Scoring System and outcome after hematopoietic cell transplantation for myelodysplastic syndrome. Blood 121:4007-8
Shadman, Mazyar; White, Emily; De Roos, Anneclaire J et al. (2013) Associations between allergies and risk of hematologic malignancies: results from the VITamins and lifestyle cohort study. Am J Hematol 88:1050-4
Gerds, Aaron T; Walter, Matthew J; Scott, Bart L (2013) Emerging importance of mutational analysis in myelodysplastic syndrome and acute myelogenous leukemia. Biol Blood Marrow Transplant 19:S33-7
Newell, L F; Flowers, M E D; Gooley, T A et al. (2013) Characteristics of chronic GVHD after cord blood transplantation. Bone Marrow Transplant 48:1285-90
Carlson, Cheryl A; Kas, Arnold; Kirkwood, Robert et al. (2012) Decoding cell lineage from acquired mutations using arbitrary deep sequencing. Nat Methods 9:78-80
Miller, Brady G; Stamatoyannopoulos, John A (2010) Integrative meta-analysis of differential gene expression in acute myeloid leukemia. PLoS One 5:e9466

Showing the most recent 10 out of 35 publications